HOME >> MEDICINE >> NEWS
Data supports extremely early intervention for multiple sclerosis patients

et will go on to develop typical MS. Consequently, a second occurrence of MS symptoms involving another part of the nervous system or definite new abnormalities that appear on magnetic resonance imaging (MRI) of the brain and spinal cord are required in order to make a definite MS diagnosis.

This study, involving patients from 32 sites across the U.S. over a five-year period, was designed to determine if much earlier treatment within a month of the appearance of initial symptoms and before a definite diagnosis had been made would delay the onset of new neurological symptoms compared to initiation of therapy more than two years after the onset of symptoms.

"The study actually evolved from an earlier investigation, known as the CHAMPS study," explains Kinkel. CHAMPS, a two-year blinded placebo controlled trial in which 383 MS patients were treated weekly with either Avonex or a placebo, found that those individuals who received Avonex experienced a 44 percent decrease in the rate of developing a second MS attack that would qualify them for a diagnosis of MS compared with the patients who received a placebo.

"We were extremely pleased with the outcome of the CHAMPS trial," notes Kinkel. "But we realized that because disabling MS symptoms such as difficulty walking and thinking that does not improve may not appear in patients for many years. We would have to conduct a much longer study to determine if Avonex actually slowed the progression of these debilitating symptoms."

To test the medication's long-term effectiveness, the study followed 203 patients, half of whom had been receiving Avonex from the onset of the CHAMPS trial (immediately after demonstrating MS symptoms) and half of whom began treatment with Avonex at a later point, following their second MS attack (or two or more years after their first attack). The study found that patients who began treatment with Avonex immediately after their first attack had a 35 perce
'"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
20-Sep-2003


Page: 1 2 3

Related medicine news :

1. Emergency department study supports giving dehydrated children fluids by mouth
2. Review supports link between HRT and stroke
3. Chamomile tea: New evidence supports health benefits
4. Social supports lessen effects of maltreatment on children vulnerable to depression
5. Study supports the use of mechanical assistance
6. Study supports aggressive treatment of heart patients with cholesterol-lowering medication
7. New data supports CellCepts position as a world leader in solid organ transplantation
8. NCI grant supports Jefferson trial to study test for colorectal cancer recurrence
9. Study supports new theory for nicotines protective effect against neurodegenerative disorders
10. New study supports use of PET scans in early diagnosis of Alzheimers disease
11. Contraception study supports convenience, simplicity

Post Your Comments:
(Date:6/18/2013)... mapped the signaling network between two previously unconnected proteins, ... cancer cell growth at its starting point. , A ... MD Anderson Cancer Center reported the tie between epidermal ... and MCM7, a protein vital to the first step ... Cancer Cell . , "MCM7 overexpression marks cell proliferation ...
(Date:6/18/2013)... myCNAjobs announces the addition of new ... and tips to the Caregiver Resources Center. , As ... 10,000+ retiring baby boomers each day, the need for ... resources has never been greater. myCNAjobs, the ... recently launched the first-ever free resource center for caregivers ...
(Date:6/18/2013)... Today, Zane Benefits, Inc. published new information ... Benefits, which provides comprehensive and flexible alternatives to traditional ... defined contribution and health reimbursement arrangement ... a company who sets up and implements a Health ... Reimbursement Accounts work. Educating employees about the benefits of ...
(Date:6/18/2013)... June 19, 2013 By studying one of ... outlined a set of successful strategies in his article ... Pages: A Case Study. , The inspirational brand Gollan ... he checked, had an impressive 62 million followers (and rising). ... Facebook’s 25 Top Facebook Pages earlier this year. The Facebook ...
(Date:6/18/2013)... University Hospitals Case Medical Center enrolled their first patients ... evaluating a novel, less-invasive procedure to help clear blockages ... year, more than 300,000 people in the United States ... artery. If left untreated, these blockages can slow or ... potentially disabling stroke, also known as a "brain attack." ...
Breaking Medicine News(10 mins):Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:Zane Benefits Publishes New Information on Health Reimbursement Accounts 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 3Health News:UH Case Medical Center among first to enroll patients for global carotid artery trial 2
(Date:6/17/2013)... June 17, 2013 Prime Therapeutics, in collaboration with ... Larsen, was awarded the Silver Anvil for its internal communication ... award was presented at the Public Relations Society of America ... 13 at the AXA Equitable Center in ... Anvil, which has been presented annually since 1946, is the ...
(Date:6/17/2013)... little known drug industry tactic to keep generic prescriptions from ... – and a ruling from the highest court in the ... better time for New Yorkers.  AARP says ... all too apparent in New York State.  According to a ... in a near Rx state of crisis, with the majority ...
(Date:6/17/2013)... Franciscan St. Francis Health Cancer Center ... Indiana to use a new drug to ... called Xofigo ®, a radiopharmaceutical used in patients with ... recently was approved for use by the U.S. Food and ... stages it may become castration-resistant, which has become resistant to ...
Breaking Medicine Technology:Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America 2Supreme Court Ruling on Rx Industry's Pay-to-Delay-Generics Good News for NY Consumers 2Supreme Court Ruling on Rx Industry's Pay-to-Delay-Generics Good News for NY Consumers 3New drug proving effective in attacking advanced prostate cancer 2
Cached News: